Search Icon
Notification Icon
Ham Icon
Quick Reads icon
Quick Reads
Events & Videos icon
Events & Videos
Explore icon
Explore
Product Index icon
Product Index
eCME icon
eCME

AMBITION Trial: Ambrisentan and Tadalafil Combo more Beneficial than Monotherapy in PAH

calendar
26 Sep, 16
Expand icon
HD Image
More From Area Of Interest
You may also like
Our Research
COMB-AR: Knowledge, Attitude, and Practice Survey Amongst Healthcare Professionals from India
12 Oct, 26
CiplaMedLogo
12 Oct, 26
Our Research
Glycemic Outcomes with VildagliptinXR Across Diabetes Duration in Indian Young-Onset T2DM: NOVELTY I...
21 Sep, 26
CiplaMedLogo
21 Sep, 26
Our Research
Understanding Post-Operative Dry Eye Disease (DED) and the Role of Sodium Hyaluronate Eye Drops (Flo...
21 Sep, 26
CiplaMedLogo
21 Sep, 26
Our Research
Dry Eye Disease: Survey on Practice Patterns and Lubricant Selection Across Disease Subtypes – Dry E...
21 Sep, 26
CiplaMedLogo
21 Sep, 26
Our Research
Efficacy & Safety of Torsemide & Spironolactone FDC in HF Patients: Insights from RESTORE HF Study
13 May, 26
CiplaMedLogo
13 May, 26
Our Research
Telmisartan & Amlodipine FDC for BP Control in Indian Patients with Hypertension: TACT‑India Study
17 Apr, 26
CiplaMedLogo
17 Apr, 26
Latest Items